Literature DB >> 23683371

The use of steroids to prevent cutaneous reactions to benznidazole in patients with Chagas disease.

Miguel Górgolas1, Ignacio Robles, Alfonso Cabello, Ramón Pérez-Tanoira, Concepción Pérez-Jorge Peremarch, Ricardo Fernández-Roblas, Frances Williams, José Manuel Ramos Rincón.   

Abstract

The treatment of Chagas disease is limited by the frequent cutaneous side effects of benznidazole. We tested the use of steroids plus escalating doses of benznidazole to prevent this complication in 17 adult patients with chronic Trypanosoma cruzi infection and found extremely good tolerance. A randomized trial is warranted.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23683371      PMCID： PMC4003594          DOI： 10.1179/2047773213Y.0000000081

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN： 2047-7724            Impact factor:   2.894


  16 in total

Review 1.  Antitrypanosomal therapy for chronic Chagas' disease.

Authors:  Caryn Bern
Journal:  N Engl J Med       Date:  2011-06-30       Impact factor: 91.245

2.  Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus.

Authors:  María-Jesús Pinazo; Gerard Espinosa; Montserrat Gállego; Paulo Luis López-Chejade; Julio A Urbina; Joaquim Gascón
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country.

Authors:  Laura Murcia; Bartolomé Carrilero; M Jose Muñoz; M Asunción Iborra; Manuel Segovia
Journal:  J Antimicrob Chemother       Date:  2010-06-11       Impact factor: 5.790

4.  Tolerance of benznidazole in treatment of Chagas' disease in adults.

Authors:  María-Jesús Pinazo; José Muñoz; Elizabeth Posada; Paulo López-Chejade; Montserrat Gállego; Edgar Ayala; Elena del Cacho; Dolors Soy; Joaquim Gascon
Journal:  Antimicrob Agents Chemother       Date:  2010-09-07       Impact factor: 5.191

5.  Prevention and handling of acute allergic and infusion reactions in oncology.

Authors:  M Joerger
Journal:  Ann Oncol       Date:  2012-09       Impact factor: 32.976

Review 6.  Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis.

Authors:  José A Pérez-Molina; Ana Pérez-Ayala; Santiago Moreno; M Carmen Fernández-González; Javier Zamora; Rogelio López-Velez
Journal:  J Antimicrob Chemother       Date:  2009-10-09       Impact factor: 5.790

7.  Cross-reactivity patterns of T cells specific for iodinated contrast media.

Authors:  Marianne Lerch; Monika Keller; Markus Britschgi; Gisele Kanny; Valerie Tache; Daphne A Schmid; Andreas Beeler; Basil O Gerber; Michael Luethi; Andreas J Bircher; Cathrine Christiansen; Werner J Pichler
Journal:  J Allergy Clin Immunol       Date:  2007-04-06       Impact factor: 10.793

Review 8.  Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.

Authors:  Rodolfo Viotti; Carlos Vigliano; Bruno Lococo; Maria Gabriela Alvarez; Marcos Petti; Graciela Bertocchi; Alejandro Armenti
Journal:  Expert Rev Anti Infect Ther       Date:  2009-03       Impact factor: 5.091

9.  [Treatment of Chagas disease with benznidazole and thioctic acid].

Authors:  Sergio Sosa-Estani; Alejandro Armenti; Graciela Araujo; Rodolfo Viotti; Bruno Lococo; Basilio Ruiz Vera; Carlos Vigliano; Ana M de Rissio; Elsa L Segura
Journal:  Medicina (B Aires)       Date:  2004       Impact factor: 0.653

10.  Prospective audit of the effectiveness of hydrocortisone premedication on drug delivery reactions following amphotericin B lipid complex *.

Authors:  Nigel O'Connor; Ann Borley
Journal:  Curr Med Res Opin       Date:  2009-03       Impact factor: 2.580
View more
  2 in total

1.  Does Progressive Introduction of Benznidazole Reduce the Chance of Adverse Events in the Treatment of Chagas Disease?

Authors:  Irene Losada Galván; Olaya Madrid Pascual; Juan María Herrero-Martínez; Ana Pérez-Ayala; Manuel Lizasoain Hernández
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

2.  Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis.

Authors:  Clara Crespillo-Andújar; Emmanuele Venanzi-Rullo; Rogelio López-Vélez; Begoña Monge-Maillo; Francesca Norman; Ana López-Polín; José A Pérez-Molina
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.228
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.